"2,2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethaneSNNCI" . "FDA"^^ . "LysodrenBRNCI" . "1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzenePTDCP07096" . "A synthetic derivative of the insecticide dichlorodiphenyl trichloroethane (DDT) with anti-adrenocorticoid properties. Following its metabolism in the adrenal cortex to a reactive acyl chloride intermediate, mitotane covalently binds to adrenal proteins, specifically inhibiting adrenal cortical hormone production. (NCI04)NCI" . "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethaneSNNCI" . "2,4'-DichlorodiphenyldichloroethaneSNNCI" . . "ChlodithaneSYDTPNSC0038721" . "39506"^^ . "Adrenocortical carcinoma"^^ . . "o,p'-DDDABNCI" . "2, 4'-DichlorodiphenyldichloroethaneSYDTPNSC0038721" . "mitotanePTNCI-GLOSSCDR0000045227" . "1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzeneSNNCI" . "Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-SYDTPNSC0038721" . "53-19-0"^^ . "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethaneSNNCI" . "WR-13045CNNCI" . "39506"^^ . "An anticancer drug used in treating adrenocortical cancer and ACTH-producing pituitary tumors (Cushing's disease).NCI-GLOSS" . "DDDABNCI" . "Cushing's Syndrome"^^ . . "ChloditanSYDTPNSC0038721" . "(o,p)-DDDSYDTPNSC0038721" . "o,p'-DDDSYDTPNSC0038721" . "KhloditanSYNCI" . "Ortho,para-DDDSYNCI" . "Mitotane"^^ . "CB 313SYDTPNSC0038721" . . "C14H10Cl4"^^ . . "C664"^^ . "MitotaneSYNCITCGA" . "CB-313CNNCI" . "o,p' - DDDABNCI" . "2, 2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethaneSYDTPNSC0038721" . "ChlodithaneSYNCI" . "C0026256"^^ . "78E4J5IB5J"^^ . "MitotanePTNCI" . "Mitotane"^^ . "38721"^^ . "MytotanSYNCI" . . "LysodrenSYDTPNSC0038721" . "ChloditanSYNCI" . "Steroid"^^ . "1, 1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethaneSYDTPNSC0038721" . "MITOTANEPTFDA78E4J5IB5J" . "Mitotane"^^ . "LisodrenFBNCI" . "Pharmacologic Substance"^^ .